Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States

Clinical trial NCT06633835 · COMPLETED

Trial details

NCT number: NCT06633835
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Vaccine-Preventable Diseases SARS CoV 2 Infection

Start date: 2024-09-19
Primary completion: 2024-12-30
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.